Any current/future new fundraising through debt or equity?

NACL Industries, Coromandel's subsidiary, successfully completed a rights issue during the quarter. The proceeds from the rights issue will be used to retire all high-cost debt and fund capex aimed at reducing costs and improving operational efficiencies for NACL plants. No specific new fundraising plans through debt or equity for Coromandel International Limited as a whole were disclosed in the call. Management is focusing on operational improvements and integration post-NACL acquisition rather than announcing fresh fundraising. Any future fundraising requirements would likely align with stra

Any current/future capex/capital investment/strategic investment?

New gypsum-based product manufacturing plant project has commenced, expected to diversify product portfolio within 15 months. Specialty Nutrient business initiated a MAP water-soluble fertilizer plant project at Vizag. Crop Protection business expanded Mancozeb capacity by 20% and plans an additional 30% expansion at Sarigam plant. Investment of approximately INR1,200 crores in backward integration projects involving sulfuric acid and phosphoric acid plants, expected to increase EBITDA per ton from INR5,500 to INR6,500. Exploration of new products, strobilurin chemistries, and agrochem

Future growth expectations in sales/revenue/volumes?

Crop Protection business grew 21% in sales for 9 months FY26, driven by 32% export and 36% domestic B2B volume growth; domestic B2C grew 5%. New product launches contributed to domestic formulation growth, with 25% of sales from new products YTD. Export business expected to expand, leveraging FTA with Europe and improved competitiveness. Fertilizer volumes grew 10% YTD in phosphatic fertilizers; consumption-based market share slightly improved from 16% to 17%. Specialty Nutrients and Nano fertilizers show strong double-digit growth; Nano DAP is market leader with 68% volume growth YTD. Retail

Future growth expectations in earnings/operating earnings/profits/EPS?

Coromandel expects to maintain an annualized fertilizer EBITDA of INR5,000-5,500 per ton despite volatility in raw material prices and currency fluctuations. Backward integration projects (sulfuric acid and phosphoric acid plants) are expected to add stable EBITDA benefits (~INR400 crores annually) from Q1 FY'27 onwards. Crop Protection & Bio-business shows strong growth, led by exports and new product launches, contributing to improved margins. NACL Industries is moving from loss-making to profit-making, with EBITDA expansion expected from Q1 FY'27 due to operational integration and efficienc

IN US

Sale is live|00:00:00left today

Coromandel International LtdQ4 FY27Fertilizers & Agrochemicals

Coromandel International Ltd Q4 FY27 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹1,971P/E: 27.6Market Cap: ₹58.5K CrSector: Fertilizers & Agrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

→Crop Protection business grew 21% in sales for 9 months FY26, driven by 32% export and 36% domestic B2B volume growth; domestic B2C grew 5%.
→New product launches contributed to domestic formulation growth, with 25% of sales from new products YTD.
→Export business expected to expand, leveraging FTA with Europe and improved competitiveness.
→Fertilizer volumes grew 10% YTD in phosphatic fertilizers; consumption-based market share slightly improved from 16% to 17%.
→Specialty Nutrients and Nano fertilizers show strong double-digit growth; Nano DAP is market leader with 68% volume growth YTD.
→Retail business grew 20% YoY, expanding stores to 1,113.
→Backward integration projects (sulfuric acid, phosphoric acid) and capacity expansions (granulation, Mancozeb) set to enhance production capabilities.
→NACL integration progressing, with profitability expected to improve from Q1 FY27.
→Overall, the company aims to sustain growth through volume expansion, new products, geographic diversification, and operational efficiencies.

Margin guidance

Category 3

→Coromandel expects to maintain an annualized fertilizer EBITDA of INR5,000-5,500 per ton despite volatility in raw material prices and currency fluctuations.
→Backward integration projects (sulfuric acid and phosphoric acid plants) are expected to add stable EBITDA benefits (~INR400 crores annually) from Q1 FY'27 onwards.
→Crop Protection & Bio-business shows strong growth, led by exports and new product launches, contributing to improved margins.
→NACL Industries is moving from loss-making to profit-making, with EBITDA expansion expected from Q1 FY'27 due to operational integration and efficiency gains.
→Retail business is growing at 20% YoY with continued network expansion.
→Specialty Nutrients and Nano DAP are on strong growth trajectories, opening up export potentials.
→Overall, Coromandel remains focused on operational excellence, cost control, and long-term value creation, underpinning steady growth in earnings and profits.

3 more insights locked — sign up free to unlock

Fundraise plans

→NACL Industries, Coromandel's subsidiary, successfully completed a rights issue during the quarter.
→The proceeds from the rights issue will be used to retire all high-cost debt and fund capex aimed at reducing costs and improving operational efficiencies for NACL plants.
→No specific new fundraising plans through debt or equity for Coromandel International Limited as a whole were disclosed in the call.
→Management is focusing on operational improvements and integration post-NACL acquisition rather than announcing fresh fundraising.
→Any future fundraising requirements would likely align with strategic expansion or integration needs, but none were explicitly stated in this call.

Order book

The provided transcript does not contain any specific information regarding the current or expected order book or pending orders for Coromandel International Limited. The discussion mainly centers around: - Q3 FY26 financial and operational performance - Fertilizer industry consumption trends - Backward integration projects and capacities - Crop protection business growth and export dynamics - Market conditions and pricing environment - Integration status of NACL acquisition - Capex and EBITDA outlook for various plants No direct reference or data about order books or pending orders is mentioned in the available text from the earnings call transcript.

Capex plans

Yes

→New gypsum-based product manufacturing plant project has commenced, expected to diversify product portfolio within 15 months.
→Specialty Nutrient business initiated a MAP water-soluble fertilizer plant project at Vizag.
→Crop Protection business expanded Mancozeb capacity by 20% and plans an additional 30% expansion at Sarigam plant.
→Investment of approximately INR1,200 crores in backward integration projects involving sulfuric acid and phosphoric acid plants, expected to increase EBITDA per ton from INR5,500 to INR6,500.
→Exploration of new products, strobilurin chemistries, and agrochemical technical expansions underway with capex held back after NACL acquisition.
→Drone spraying business scaling, covering close to 2 lakh acres in 9 months, aiming for precision application solutions.
→Continuous evaluation of global market opportunities for nano DAP and bio products for exports and new product registrations.
→Mining business in Senegal scaling production, ensuring supply security for raw materials and strategic value addition.

How does Coromandel International Ltd rank vs peers in Fertilizers & Agrochemicals?

Pro feature

1Coromandel International Ltd

Rev 3Mar 3

See full Fertilizers & Agrochemicals sector rankings

Want more stocks like Coromandel International Ltd?

Build an AI portfolio filtered by sector, market cap, and growth rank. Takes 2 minutes.

Build my portfolio